| Dr Eduardo Miguel Vidal, MD | |
|
1400 Hal Greer Blvd Fl 2, Huntington, WV 25701-4114 | |
| (304) 691-1930 | |
| Not Available |
| Full Name | Dr Eduardo Miguel Vidal |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 25 Years |
| Location | 1400 Hal Greer Blvd Fl 2, Huntington, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356327951 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | ME83671 (Florida) | Secondary |
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | 30229 (West Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Dermatology Sc | 8628353380 | 160 |
News Archive
Doctors at Cincinnati Children's Hospital Medical Center want to make sure children are safe this summer when they are playing in or around water.
Approximately 13 percent of parents turn to alternative therapies to treat their children's asthma, according to a new study from the Universit- de Montr-al. The findings, published recently in the Canadian Respiratory Journal, suggest that this trend is associated with a two-fold higher rate of poor asthma control in children.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has granted a priority review designation to BENLYSTA (belimumab) as a potential treatment for systemic lupus erythematosus.
Hospitalizations for heart conditions, neurological illness, and other conditions were higher among people who live near unconventional gas and oil drilling (hydraulic fracturing), according to new research from the University of Pennsylvania and Columbia University published this week in PLOS ONE.
Axentis Pharma AG has initiated a clinical phase IIa trial to assess the safety and tolerability of a new therapeutic formulation for the treatment of severe pulmonary infection in cystic fibrosis patients. The new formulation allows an established therapeutic agent to be delivered directly to the site of infection. The forthcoming trial will also compare the effects of two different doses of the new drug.
› Verified 7 days ago
| Entity Name | Pinnacle Dermatology Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861930984 PECOS PAC ID: 8628353380 Enrollment ID: O20200911001979 |
News Archive
Doctors at Cincinnati Children's Hospital Medical Center want to make sure children are safe this summer when they are playing in or around water.
Approximately 13 percent of parents turn to alternative therapies to treat their children's asthma, according to a new study from the Universit- de Montr-al. The findings, published recently in the Canadian Respiratory Journal, suggest that this trend is associated with a two-fold higher rate of poor asthma control in children.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has granted a priority review designation to BENLYSTA (belimumab) as a potential treatment for systemic lupus erythematosus.
Hospitalizations for heart conditions, neurological illness, and other conditions were higher among people who live near unconventional gas and oil drilling (hydraulic fracturing), according to new research from the University of Pennsylvania and Columbia University published this week in PLOS ONE.
Axentis Pharma AG has initiated a clinical phase IIa trial to assess the safety and tolerability of a new therapeutic formulation for the treatment of severe pulmonary infection in cystic fibrosis patients. The new formulation allows an established therapeutic agent to be delivered directly to the site of infection. The forthcoming trial will also compare the effects of two different doses of the new drug.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eduardo Miguel Vidal, MD 1400 Hal Greer Blvd Fl 2, Huntington, WV 25701-4114 Ph: (304) 691-1930 | Dr Eduardo Miguel Vidal, MD 1400 Hal Greer Blvd Fl 2, Huntington, WV 25701-4114 Ph: (304) 691-1930 |
News Archive
Doctors at Cincinnati Children's Hospital Medical Center want to make sure children are safe this summer when they are playing in or around water.
Approximately 13 percent of parents turn to alternative therapies to treat their children's asthma, according to a new study from the Universit- de Montr-al. The findings, published recently in the Canadian Respiratory Journal, suggest that this trend is associated with a two-fold higher rate of poor asthma control in children.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has granted a priority review designation to BENLYSTA (belimumab) as a potential treatment for systemic lupus erythematosus.
Hospitalizations for heart conditions, neurological illness, and other conditions were higher among people who live near unconventional gas and oil drilling (hydraulic fracturing), according to new research from the University of Pennsylvania and Columbia University published this week in PLOS ONE.
Axentis Pharma AG has initiated a clinical phase IIa trial to assess the safety and tolerability of a new therapeutic formulation for the treatment of severe pulmonary infection in cystic fibrosis patients. The new formulation allows an established therapeutic agent to be delivered directly to the site of infection. The forthcoming trial will also compare the effects of two different doses of the new drug.
› Verified 7 days ago
Charles L Yarbrough, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1934 11th Ave, Huntington, WV 25701 Phone: 304-529-0900 Fax: 304-529-3913 | |
Elaine M Young, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1411 6th Ave, Huntington, WV 25701 Phone: 304-525-6132 Fax: 304-697-0471 | |
Vincent Adams, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1600 Medical Center Dr Ste 2000, Huntington, WV 25701 Phone: 304-691-1200 | |
Sandra E Marshall, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5170 Us Route 60 E, Huntington, WV 25705 Phone: 304-528-4632 Fax: 304-697-3249 | |
Dr. Soham Chaudhari, D.O Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1934 11th Ave, Huntington, WV 25701 Phone: 304-529-0900 | |
Shane Cook, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1934 11th Ave, Huntington, WV 25701 Phone: 304-529-0900 |